IRIS Accounts Production v25.2.0.378 07828427 Board of Directors 1.1.24 31.12.24 31.12.24 false true false false true false A Ordinary 0.01000 C Ordinary 0.01000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh078284272023-12-31078284272024-12-31078284272024-01-012024-12-31078284272022-12-31078284272023-01-012023-12-31078284272023-12-3107828427ns15:EnglandWales2024-01-012024-12-3107828427ns14:PoundSterling2024-01-012024-12-3107828427ns10:Director12024-01-012024-12-3107828427ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3107828427ns10:SmallEntities2024-01-012024-12-3107828427ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-3107828427ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3107828427ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3107828427ns10:FullAccounts2024-01-012024-12-3107828427ns10:OrdinaryShareClass12024-01-012024-12-3107828427ns10:OrdinaryShareClass22024-01-012024-12-3107828427ns10:Director22024-01-012024-12-3107828427ns10:Director32024-01-012024-12-3107828427ns10:Director42024-01-012024-12-3107828427ns10:RegisteredOffice2024-01-012024-12-3107828427ns5:CurrentFinancialInstruments2024-12-3107828427ns5:CurrentFinancialInstruments2023-12-3107828427ns5:Non-currentFinancialInstruments2024-12-3107828427ns5:Non-currentFinancialInstruments2023-12-3107828427ns5:ShareCapital2024-12-3107828427ns5:ShareCapital2023-12-3107828427ns5:SharePremium2024-12-3107828427ns5:SharePremium2023-12-3107828427ns5:RetainedEarningsAccumulatedLosses2024-12-3107828427ns5:RetainedEarningsAccumulatedLosses2023-12-3107828427ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3107828427ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3107828427ns10:OrdinaryShareClass12024-12-3107828427ns10:OrdinaryShareClass22024-12-31
REGISTERED NUMBER: 07828427 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 December 2024

for

Halcyon Doctors Limited

Halcyon Doctors Limited (Registered number: 07828427)

Contents of the Financial Statements
for the Year Ended 31 December 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Halcyon Doctors Limited

Company Information
for the Year Ended 31 December 2024







DIRECTORS: D K Gunasinghe
Ms T Taylor Mathews
R A M Van Den Brink
D M P L T Vlerick





REGISTERED OFFICE: Unit 1 The Cam Centre
Wilbury Way
Hitchin
Hertfordshire
SG4 0TW





REGISTERED NUMBER: 07828427 (England and Wales)






Halcyon Doctors Limited (Registered number: 07828427)

Balance Sheet
31 December 2024

2024 2023
Notes £    £   
CURRENT ASSETS
Debtors 4 35,454 23,956
Cash at bank 44,221 68,090
79,675 92,046
CREDITORS
Amounts falling due within one year 5 (74,445 ) (86,296 )
NET CURRENT ASSETS 5,230 5,750
TOTAL ASSETS LESS CURRENT
LIABILITIES

5,230

5,750

CREDITORS
Amounts falling due after more than one
year

6

(1,322,017

)

(1,317,372

)
NET LIABILITIES (1,316,787 ) (1,311,622 )

CAPITAL AND RESERVES
Called up share capital 8 15,348 15,348
Share premium 1,002,045 1,002,045
Retained earnings (2,334,180 ) (2,329,015 )
SHAREHOLDERS' FUNDS (1,316,787 ) (1,311,622 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Profit and Loss. has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 13 June 2025 and were signed on its behalf by:





D K Gunasinghe - Director


Halcyon Doctors Limited (Registered number: 07828427)

Notes to the Financial Statements
for the Year Ended 31 December 2024


1. STATUTORY INFORMATION

Halcyon Doctors Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared using the historical cost convention except that as
disclosed in the accounting policies certain items are shown at fair value.
The financial statements are prepared in sterling, which is the functional currency of the entity.

Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102
Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and
Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small
companies' regime).

Judgements
The preparation of the financial statements requires management to make judgements, estimates and
assumptions that affect the amounts reported. These estimates and judgements are continually
reviewed and are based on experience and other factors, including expectations of future events that
are believed to be reasonable under the circumstances.

Going concern
The financial statements have been prepared on a going concern basis. The company has net current
liabilities and a negative balance sheet at the year end and has recorded a loss in the current year.
The Directors believe that the company is a going concern on the basis of its knowledge of future
income streams and cost base, on this basis the Directors consider it appropriate to prepare the
accounts on a going concern basis.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Profit and Loss., except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Revenue recognition
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Halcyon Doctors Limited (Registered number: 07828427)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024


2. ACCOUNTING POLICIES - continued

Cash and cash equivalents
Cash and cash equivalents comprise cash on hand and call deposits.

Trade debtors
Trade debtors are amounts due from customers for merchandise sold or services performed in the
ordinary course of business.

Trade creditors
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary
course of business from suppliers. Accounts payable are classified as current liabilities if the company
does not have an unconditional right, at the end of the reporting period, to defer settlement of the
creditor for at least twelve months after the reporting date. If there is an unconditional right to defer
settlement for at least twelve months after the reporting date, they are presented as non-current
liabilities.
Trade creditors are recognised at the transaction price.

Share capital
Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash
or other resources received or receivable, net of the direct costs of issuing the equity instruments. If
payment is deferred and the time value of money is material, the initial measurement is on a present
value basis.

Defined contribution pension obligation
A defined contribution plan is a pension plan under which fixed contributions are paid into a pension
fund and the company has no legal or constructive obligation to pay further contributions even if the
fund does not hold sufficient assets to pay all employees the benefits relating to employee service in
the current and prior periods.
Contributions to defined contribution plans are recognised as employee benefit expense when they
are due. If contribution payments exceed the contribution due for service, the excess is recognised as
a prepayment.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 6 (2023 - 7 ) .

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 26,555 17,385
Other debtors 8,899 6,571
35,454 23,956

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 43,124 41,265
Taxation and social security 24,585 27,925
Other creditors 6,736 17,106
74,445 86,296

6. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£    £   
Other creditors 1,322,017 1,317,372

Halcyon Doctors Limited (Registered number: 07828427)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024


6. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR - continued
2024 2023
£    £   
Amounts falling due in more than five years:

Repayable by instalments
Other loans more 5yrs instal 1,322,017 1,317,372

7. LOANS

An analysis of the maturity of loans is given below:

2024 2023
£    £   
Amounts falling due within one year or on demand:
Other loans 5,001 15,000

Amounts falling due in more than five years:

Repayable by instalments
Other loans more 5yrs instal 1,322,017 1,317,372

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
1,341,142 A Ordinary 0.01 13,411 13,411
193,658 C Ordinary 0.01 1,937 1,937
15,348 15,348

9. RELATED PARTY DISCLOSURES

At the balance sheet date D Gunasinghe owed £300 (2023: £300), R Van Den Brink owed £1200
(2023: £1200) and J Warner owed £100 (2023: £100) for unpaid share capital, all Directors of the
company. At the balance sheet date the company owed R Van Den Brink £84,008 (2023: £80,777),
there are no terms for repayment and interest is charged at 4% per annum.
The unsecured loans are from relations of the Directors. There are no formal terms for repayment and
interest is being charged at 4% per annum.